Learn more

PAEAN BIOTECHNOLOGY INC

Overview
  • Total Patents
    46
  • GoodIP Patent Rank
    32,806
  • Filing trend
    ⇩ 70.0%
About

PAEAN BIOTECHNOLOGY INC has a total of 46 patent applications. It decreased the IP activity by 70.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHAMELEON BIOSCIENCES INC, DEISSEROTH ALBERT B and TESSA THERAPEUTICS PTE LTD.

Patent filings per year

Chart showing PAEAN BIOTECHNOLOGY INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Han Kyuboem 25
#2 Hwang Jung Uk 20
#3 Choi Yong-Soo 18
#4 Kim Chun-Hyung 16
#5 Kim Chun Hyung 14
#6 Kim Mi Jin 13
#7 Lee Youngjun 12
#8 Kim Yu Jin 11
#9 Choi Yong Soo 10
#10 Ha Jong Cheon 10

Latest patents

Publication Filing date Title
KR20200056363A Pharmaceutical composition for preventing hair loss and promoting hair growth comprising isolated mitochondria
KR20200126929A Pharmaceutical composition for preventing or treating myositis comprising isolated mitochondria as effective ingredient
WO2020222483A1 Pharmaceutical composition for treating sepsis or systemic inflammatory response syndrome, comprising isolated mitochondria as active ingredient
KR20190092348A Composition for preventing or treating ischemic diseases comprising mitochondria
KR20200038167A FIBROBLAST GROWTH FACTOR-5s MUTANTS AND COMPOSITION COMPRISING SAME FOR PREVENTING HAIR LOSS
KR20190124656A Modified mitochondria and use thereof
WO2019151840A1 Pharmaceutical composition comprising isolated mitochondria for prevention or treatment of rheumatoid arthritis
KR20190063445A A microparticle comprising hedgehog protein and biocompatible material and a composition for preventing or treating hair loss comprising the same
KR20190012129A Composition for improving the stability of high molecular weight hyaluronic acid and dermal filler comprising the same
KR20180099537A Pharmaceutical formulation for treatment of fibrosis caused by pathological activation of myofibroblast
CN110022884A Pharmaceutical composition containing mitochondrial
KR20190061181A Pharmaceutical composition for preventing hair loss and promoting hair growth comprising isolated mitochondria
KR101846460B1 Method for transferring foreign mitochondria into cell
EP3540048A2 Natural killer cell containing exogenous mitochondrium and pharmaceutical composition comprising same
KR20180119767A Direct Conversion of Human Fibroblasts to Neural Precursor Cells Using Sox2 Protein Fused with Cell-penetrating Peptide
KR20180119761A Method of expressing a target protein on the surface of human cell membrane using the transmembrane anchored domain of signal transduction membrane protein
KR20180100029A Preparation Process for CCN5 protein by using transfected E. coli
KR20180100028A Preparation Process for CCN5 protein by using transfected CHO
KR20180085124A Anti-allergy Compositions Comprising Extraction of Cephalotaxus or Homoharringtonine Separated from the Extraction
KR20180025517A Non-aqueous composition comprising nucleotide mixture originated from flower parts of plant